Post ISTH & ASH Headlines 2019


Abstracts selected by Dr John Grainger (Manchester)

Abstract 3
Realizing Effectiveness across Continents with Hydroxyurea (REACH): A Prospective Multi-National Trial of Hydroxyurea for Sickle Cell Anemia in Sub-Saharan Africa
Abstract (PDF) 

Abstract 507
Clinical and Laboratory Benefits of Early Initiation of Hydroxyurea with Pharmacokinetic Guided Dosing for Young Children with Sickle Cell Anemia
Abstract (PDF)


Abstract 506
Probability of TCD-Normalization in the “Drepagreffe” Trial Comparing Transplantation to Chronic Transfusion in Sickle Cell Anemia Children with Abnormal-Transcranial Doppler Is Associated with Lower Ang-2 and BDNF Plasma Levels
Abstract (PDF)


Abstract 2428
Safety and Efficacy of Romiplostim in over 200 Children with Immune Thrombocytopenia (ITP): Results of an Integrated Database of 5 Clinical Trials
Abstract (PDF)


Abstract 382
Early Prophylaxis Provides Continued Joint Protection in Severe Hemophilia A: Results of the Joint Outcome Continuation Study
Abstract (PDF)


Abstract 632
Emicizumab Prophylaxis Provides Flexible and Effective Bleed Control in Children with Hemophilia Α with Inhibitors: Results from the HAVEN 2 Study
Abstract (PDF)


Abstract 634
The Atlanta Protocol: Immune Tolerance Induction in Pediatric Patients with Hemophilia a and Inhibitors on Emicizumab
Abstract (PDF)


Abstract 142
Risk Factors for Hospital-Acquired Venous Thromboembolism in Children: Findings from the Children’s Hospital-Acquired Thrombosis (CHAT) Registry
Abstract (PDF)